Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Chronic Renal Failure

  Free Subscription


18.02.2019

1 Am J Kidney Dis
2 Clin J Am Soc Nephrol
2 J Am Soc Nephrol
1 J Nephrol
1 Nephrol Dial Transplant
1 Nephron
2 PLoS One
2 Ren Fail
5 Transplant Proc
4 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Kidney Dis

  1. NAYLOR KL, Kim SJ, McArthur E, Garg AX, et al
    Mortality in Incident Maintenance Dialysis Patients Versus Incident Solid Organ Cancer Patients: A Population-Based Cohort.
    Am J Kidney Dis. 2019 Jan 28. pii: S0272-6386(18)31126.
    PubMed     Text format     Abstract available


    Clin J Am Soc Nephrol

  2. ADWANEY A, Lim C, Blakey S, Duncan N, et al
    Central Venous Stenosis, Access Outcome and Survival in Patients undergoing Maintenance Hemodialysis.
    Clin J Am Soc Nephrol. 2019 Feb 14. pii: CJN.07010618. doi: 10.2215/CJN.07010618
    PubMed     Text format     Abstract available

  3. MADERO M, Cano KB, Campos I, Tao X, et al
    Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor.
    Clin J Am Soc Nephrol. 2019 Feb 12. pii: CJN.05240418. doi: 10.2215/CJN.05240418
    PubMed     Text format     Abstract available


    J Am Soc Nephrol

  4. AU EH, Chapman JR, Craig JC, Lim WH, et al
    Overall and Site-Specific Cancer Mortality in Patients on Dialysis and after Kidney Transplant.
    J Am Soc Nephrol. 2019 Feb 14. pii: ASN.2018090906. doi: 10.1681/ASN.2018090906.
    PubMed     Text format     Abstract available

  5. FLYTHE JE, Narendra JH, Hilliard T, Frazier K, et al
    Cultivating a Research-Ready Dialysis Community.
    J Am Soc Nephrol. 2019 Feb 8. pii: ASN.2018101059. doi: 10.1681/ASN.2018101059.
    PubMed     Text format    


    J Nephrol

  6. FUSARO M, Gallieni M, Aghi A, Rizzo MA, et al
    Osteocalcin (bone GLA protein) levels, vascular calcifications, vertebral fractures and mortality in hemodialysis patients with diabetes mellitus.
    J Nephrol. 2019 Feb 13. pii: 10.1007/s40620-019-00595.
    PubMed     Text format     Abstract available


    Nephrol Dial Transplant

  7. SARAFIDIS P, Ferro CJ, Morales E, Ortiz A, et al
    SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.
    Nephrol Dial Transplant. 2019;34:208-230.
    PubMed     Text format     Abstract available


    Nephron

  8. YALIN SF, Eren N, Sinangil A, Yilmaz VT, et al
    Fabry Disease Prevalence in Renal Replacement Therapy in Turkey.
    Nephron. 2019 Feb 8:1-8. doi: 10.1159/000496620.
    PubMed     Text format     Abstract available


    PLoS One

  9. YAJIMA T, Arao M, Yajima K, Takahashi H, et al
    The associations of fat tissue and muscle mass indices with all-cause mortality in patients undergoing hemodialysis.
    PLoS One. 2019;14:e0211988.
    PubMed     Text format     Abstract available

  10. JANSZ TT, Neradova A, van Ballegooijen AJ, Verhaar MC, et al
    The role of kidney transplantation and phosphate binder use in vitamin K status.
    PLoS One. 2018;13:e0203157.
    PubMed     Text format     Abstract available


    Ren Fail

  11. YE Y, Liu H, Chen Y, Zhang Y, et al
    Hemoglobin targets for the anemia in patients with dialysis-dependent chronic kidney disease: a meta-analysis of randomized, controlled trials.
    Ren Fail. 2018;40:671-679.
    PubMed     Text format     Abstract available

  12. MASAJTIS-ZAGAJEWSKA A, Nowicki M
    Effect of atorvastatin on iron metabolism regulation in patients with chronic kidney disease - a randomized double blind crossover study.
    Ren Fail. 2018;40:700-709.
    PubMed     Text format     Abstract available


    Transplant Proc

  13. MATSUMURA S, Unagami K, Okabe S, Fukuda H, et al
    Comparative Study on Variation of Quality of Life of Patients of Preemptive Kidney Transplantation and Nonpreemptive Kidney Transplantation.
    Transplant Proc. 2018;50:3321-3328.
    PubMed     Text format     Abstract available

  14. APEWOKIN S, Madan R, Restrepo A, Hemmige VS, et al
    Clinical and Health Care Utilization Outcomes of Kidney Transplantation in HIV-Positive Recipients: A Nationwide Analysis From 2008-2013.
    Transplant Proc. 2018;50:3361-3366.
    PubMed     Text format     Abstract available

  15. KLEINSTEUBER A, Halleck F, Khadzhynov D, Staeck A, et al
    Impact of Pre-existing Comorbidities on Long-term Outcomes in Kidney Transplant Recipients.
    Transplant Proc. 2018;50:3232-3241.
    PubMed     Text format     Abstract available

  16. VAN HOOGDALEM LE, Hoitsma A, Timman R, van der Zwart R, et al
    Shared Decision-Making in Kidney Patients: Involvement in Decisions Regarding the Quality of Deceased Donor Kidneys.
    Transplant Proc. 2018;50:3152-3159.
    PubMed     Text format     Abstract available

  17. BEJIC M, Deglise S, Venetz JP, Nseir G, et al
    Use of Intraoperative Duplex Ultrasound and Resistance Index Reduces Complications in Living Renal Donor Transplantation.
    Transplant Proc. 2018;50:3192-3198.
    PubMed     Text format     Abstract available


    Transplantation

  18. HAN F, Wan S, Sun Q, Chen N, et al
    Donor Plasma Mitochondrial DNA is Correlated with Posttransplant Renal Allograft Function.
    Transplantation. 2019 Feb 4. doi: 10.1097/TP.0000000000002598.
    PubMed     Text format     Abstract available

  19. SUSAL C, Morath C
    Is Belatacept Switch Safe in Renal Transplant Recipients With Donor-Specific Antibodies?
    Transplantation. 2019 Feb 4. doi: 10.1097/TP.0000000000002588.
    PubMed     Text format    

  20. LOON EV, Naesens M
    Single nucleotide polymorphisms in renal transplantation: Can't see the wood for the trees.
    Transplantation. 2019 Feb 7. doi: 10.1097/TP.0000000000002661.
    PubMed     Text format    

  21. HINOJOSA RJ, Chaffin K, Gillespie M, Villarreal VH Jr, et al
    Donor-derived cell-free DNA (dd-cfDNA) may confirm real-time response to treatment of acute rejection in renal transplant recipients.
    Transplantation. 2019 Feb 4. doi: 10.1097/TP.0000000000002579.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: